Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00056667 · ClinicalTrials.gov registry record · Phase 4
Relaxation Response Training for the Treatment of Rheumatoid Arthritis
A Phase 4 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 168
- Enrollment target
NCT00056667 is a Phase 4 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 168 participants.
The verdict
NCT00056667, a Phase 4 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 168 participants
- Enrollment target
Study Summary
This study will evaluate the relative effectiveness of Relaxation Response (RR) training for the treatment of rheumatoid arthritis (RA). The study will compare RR training to RR training with cognitive behavioral therapy and to a standard RA education program.
Interventions
- BEHAVIORAL Relaxation response
- BEHAVIORAL Relaxation response and cognitive behavioral therapy
- OTHER RA education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2001-07 |
| Est. Completion | 2006-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00056667
The ClinicalTrials.gov registry entry for NCT00056667 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Relaxation response is the first listed.
NCT00056667 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00056667 about?
NCT00056667 is a clinical study titled "Relaxation Response Training for the Treatment of Rheumatoid Arthritis". This study will evaluate the relative effectiveness of Relaxation Response (RR) training for the treatment of rheumatoid arthritis (RA). The study will compare RR training to RR training with cognitive behavioral therapy and to a standard RA education program.
What is the current status of trial NCT00056667?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 168 participants. The study started on 2001-07. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00056667?
The interventions under investigation include: Relaxation response (BEHAVIORAL), Relaxation response and cognitive behavioral therapy (BEHAVIORAL), RA education (OTHER).
Who is sponsoring clinical trial NCT00056667?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.